Avalon Trust’s Eli Lilly LLY Stock Holding History

Avalon Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$781K	Sell	849 -42	-5%	-$42.6K	0.05%	75
2025 Q4	$958K	Sell	891 -75	-8%	-$71.7K	0.06%	72
2025 Q3	$737K	Buy	966 +85	+10%	+$63.3K	0.05%	81
2025 Q2	$687K	Hold	881	–	–	0.05%	79
2025 Q1	$728K	Hold	881	–	–	0.06%	81
2024 Q4	$680K	Buy	881 +11	+1%	+$9.11K	0.05%	82
2024 Q3	$771K	Sell	870 -55	-6%	-$49.4K	0.06%	77
2024 Q2	$837K	Sell	925 -15	-2%	-$12K	0.07%	73
2024 Q1	$731K	Sell	940 -55	-6%	-$39.1K	0.06%	78
2023 Q4	$580K	Buy	995 +267	+37%	+$156K	0.05%	81
2023 Q3	$391K	Sell	728 -200	-22%	-$103K	0.04%	86
2023 Q2	$435K	Buy	928 +605	+187%	+$254K	0.04%	89
2023 Q1	$111K	Buy	+323	New	+$109K	0.01%	151

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Avalon Trust's LLY Position: Q1 2026 in Review

Avalon Trust reduced its Eli Lilly (LLY) stake by 4.7% in Q1 2026, selling an estimated $42.6K and leaving 849 shares worth $781K. The position accounts for 0.05% of the portfolio, ranked #75.

Avalon Trust first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $958K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Avalon Trust held 849 shares of Eli Lilly worth $781K as of Q1 2026.
Avalon Trust sold 42 Eli Lilly shares in Q1 2026, an estimated $42.6K.
Eli Lilly made up 0.05% of Avalon Trust's portfolio in Q1 2026, its #75 holding.
Avalon Trust first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
Avalon Trust's Eli Lilly position peaked at $958K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.